Search Results - "Hyde, Lynn"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    fMRI study of olfactory processing in mice under three anesthesia protocols: Insight into the effect of ketamine on olfactory processing by Zhao, Fuqiang, Meng, Xiangjun, Lu, Sherry, Hyde, Lynn A., Kennedy, Matthew E., Houghton, Andrea K., Evelhoch, Jeffrey L., Hines, Catherine D.G.

    Published in NeuroImage (Orlando, Fla.) (01-06-2020)
    “…Functional magnetic resonance imaging (fMRI) is a valuable tool for studying neural activations in the central nervous system of animals due to its wide…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Pharmacological BACE Inhibition Improves Axonal Regeneration in Nerve Injury and Disease Models by Tallon, Carolyn, Marshall, Katherine L., Kennedy, Matthew E., Hyde, Lynn A., Farah, Mohamed. H.

    Published in Neurotherapeutics (01-07-2020)
    “…While the peripheral nervous system is able to repair itself following injury and disease, recovery is often slow and incomplete, with no available treatments…”
    Get full text
    Journal Article
  7. 7

    Design and discovery of C2-fluoroalkyl iminothiazine dioxides as BACE inhibitors by Taoka, Brandon M., Wu, Wen-Lian, Hao, Jinsong, Dolmaski, Martin, Wang, Hongwu, Levorse, Dorothy, Orth, Peter, Hyde, Lynn A., Smith, Brad, Michener, Maria S., Kennedy, Matthew E., Parker, Eric M., Cumming, Jared N.

    Published in Bioorganic & medicinal chemistry letters (15-01-2022)
    “…[Display omitted] This paper describes the structure–activity-relationships of novel fluoroalkyl substituents at the C2 position of iminothiazine dioxide beta…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Chronic Verubecestat Treatment Suppresses Amyloid Accumulation in Advanced Aged Tg2576-AβPPswe Mice Without Inducing Microhemorrhage by Villarreal, Stephanie, Zhao, Fuqiang, Hyde, Lynn A, Holder, Daniel, Forest, Thomas, Sondey, Marie, Chen, Xia, Sur, Cyrille, Parker, Eric M, Kennedy, Matthew E

    Published in Journal of Alzheimer's disease (01-01-2017)
    “…Verubecestat is a potent BACE1 enzyme inhibitor currently being investigated in Phase III trials for the treatment of mild-to-moderate and prodromal…”
    Get more information
    Journal Article
  10. 10
  11. 11

    MitoPark mice, an animal model of Parkinson's disease, show enhanced prepulse inhibition of acoustic startle and no loss of gating in response to the adenosine A(2A) antagonist SCH 412348 by Grauer, Steven M, Hodgson, Robert, Hyde, Lynn A

    Published in Psychopharmacology (01-04-2014)
    “…Psychoses are debilitating side effects associated with current dopaminergic treatments for Parkinson's disease (PD). Prepulse inhibition (PPI), in which a…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Analysis of tau post-translational modifications in rTg4510 mice, a model of tau pathology by Song, Lixin, Lu, Sherry X, Ouyang, Xuesong, Melchor, Jerry, Lee, Julie, Terracina, Giuseppe, Wang, Xiaohai, Hyde, Lynn, Hess, J Fred, Parker, Eric M, Zhang, Lili

    Published in Molecular neurodegeneration (26-03-2015)
    “…Microtubule associated protein tau is the major component of the neurofibrillary tangles (NFTs) found in the brains of patients with Alzheimer's disease and…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Discovery of a Tetrahydrobenzisoxazole Series of γ‑Secretase Modulators by Zhao, Zhiqiang, Pissarnitski, Dmitri A, Huang, Xianhai, Palani, Anandan, Zhu, Zhaoning, Greenlee, William J, Hyde, Lynn A, Song, Lixin, Terracina, Giuseppe, Zhang, Lili, Parker, Eric M

    Published in ACS medicinal chemistry letters (12-10-2017)
    “…The design and synthesis of a new series of tetrahydrobenzisoxazoles as modulators of γ-secretase activity and their structure–activity relationship (SAR) will…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Increased seizure threshold and severity in young transgenic CRND8 mice by Del Vecchio, Robert A., Gold, Lisa H., Novick, Steve J., Wong, Gwen, Hyde, Lynn A.

    Published in Neuroscience letters (02-09-2004)
    “…Reports suggest that Alzheimer’s disease (AD) patients show a high life-time prevalence of seizure-like disorders. The transgenic CRND8 (TgCRDN8) is a mouse…”
    Get full text
    Journal Article
  19. 19
  20. 20